Muscle Metabolism and Oxygenation During Localized Fatigue-exercise in COPD
Launched by LAVAL UNIVERSITY · Jul 23, 2013
Trial Information
Current as of June 24, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • COPD (FEV1/FVC \< 0.70 and FEV1 \< 0.80 predicted
- • Healthy subjects: no evidence of airways obstruction (FEV1/FVC \> 0.70 and FEV1 \> 0.80 predicted)
- • Smoking history \> 15 pack-years
- Exclusion Criteria:
- • Chronic hypoxemia and/or hypercapnia (PaO2 \< 60 mmHg or SpO2 \< 88% at rest and/or PaCO2 \> 45 mmHg)
- • Recent exacerbation (\< 3 months)
- • Recent cancer (\< 3 years)
- • Diabetes
- • Myopathy, neuromuscular or articular disease
- • Unstable cardiac disease
- • Absolute contraindications to exercise testing
- • Regular physical activity or exercise training program in the last 2 months
- • Physical activity score \> 9 in the Voorips questionnaire
- • Thigh skinfold thickness \> 15 mm
- • BMI \> 30
About Laval University
Laval University is a prestigious research institution located in Quebec, Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. The university actively engages in clinical trials aimed at exploring new therapeutic interventions and improving patient outcomes. With a strong emphasis on ethical standards and rigorous scientific methodologies, Laval University collaborates with multidisciplinary teams of researchers, healthcare professionals, and industry partners to conduct high-quality clinical research. Its state-of-the-art facilities and dedication to fostering a culture of inquiry position Laval University as a leader in clinical research, contributing significantly to the understanding and treatment of diverse medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Québec, Quebec, Canada
Patients applied
Trial Officials
François Maltais, MD
Principal Investigator
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials